Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sphingomyelins | 3 | 2020 | 105 | 1.430 |
Why?
|
| Plant Extracts | 2 | 2018 | 499 | 0.950 |
Why?
|
| Eggs | 4 | 2020 | 182 | 0.910 |
Why?
|
| Lipoproteins, HDL | 2 | 2018 | 682 | 0.890 |
Why?
|
| Diet, Sodium-Restricted | 2 | 2021 | 291 | 0.790 |
Why?
|
| Milk | 4 | 2022 | 438 | 0.780 |
Why?
|
| Dairy Products | 2 | 2022 | 490 | 0.760 |
Why?
|
| Eating | 4 | 2022 | 1542 | 0.740 |
Why?
|
| Atherosclerosis | 3 | 2022 | 3433 | 0.690 |
Why?
|
| Sambucus nigra | 1 | 2018 | 4 | 0.640 |
Why?
|
| Vitis | 1 | 2018 | 19 | 0.630 |
Why?
|
| Radius | 1 | 2021 | 443 | 0.620 |
Why?
|
| Caloric Restriction | 1 | 2021 | 301 | 0.610 |
Why?
|
| Independent Living | 1 | 2022 | 584 | 0.570 |
Why?
|
| Diet | 6 | 2023 | 8089 | 0.540 |
Why?
|
| Tibia | 1 | 2021 | 1076 | 0.510 |
Why?
|
| Diet, Mediterranean | 1 | 2022 | 748 | 0.500 |
Why?
|
| Flavonoids | 2 | 2023 | 447 | 0.480 |
Why?
|
| Lipoproteins | 1 | 2020 | 880 | 0.480 |
Why?
|
| Cholesterol | 3 | 2020 | 2914 | 0.460 |
Why?
|
| Hypolipidemic Agents | 1 | 2018 | 609 | 0.450 |
Why?
|
| Hyperlipidemias | 1 | 2018 | 772 | 0.440 |
Why?
|
| Cholesterol, HDL | 2 | 2017 | 1820 | 0.440 |
Why?
|
| Fruit | 1 | 2018 | 1165 | 0.420 |
Why?
|
| Osteoporosis | 1 | 2022 | 1605 | 0.400 |
Why?
|
| Patient Selection | 1 | 2024 | 4260 | 0.400 |
Why?
|
| Internet | 1 | 2024 | 3110 | 0.400 |
Why?
|
| Bone Density | 2 | 2022 | 3573 | 0.380 |
Why?
|
| Aorta | 1 | 2019 | 2045 | 0.370 |
Why?
|
| Plaque, Atherosclerotic | 2 | 2020 | 1551 | 0.350 |
Why?
|
| Aryldialkylphosphatase | 3 | 2018 | 64 | 0.340 |
Why?
|
| Sodium, Dietary | 3 | 2021 | 426 | 0.310 |
Why?
|
| Clinical Trials as Topic | 1 | 2024 | 8052 | 0.310 |
Why?
|
| Diet Surveys | 2 | 2022 | 1160 | 0.290 |
Why?
|
| Hypertension | 3 | 2022 | 8616 | 0.270 |
Why?
|
| Software | 1 | 2021 | 4480 | 0.270 |
Why?
|
| Antioxidants | 3 | 2018 | 1676 | 0.250 |
Why?
|
| Depression | 1 | 2023 | 8230 | 0.210 |
Why?
|
| Flavonols | 1 | 2023 | 85 | 0.210 |
Why?
|
| Quercetin | 1 | 2023 | 97 | 0.210 |
Why?
|
| Bacteroidetes | 1 | 2022 | 84 | 0.190 |
Why?
|
| Interleukin-6 | 2 | 2022 | 3229 | 0.180 |
Why?
|
| Male | 19 | 2024 | 364731 | 0.170 |
Why?
|
| Cholesterol, Dietary | 1 | 2020 | 224 | 0.160 |
Why?
|
| Carotenoids | 1 | 2022 | 620 | 0.160 |
Why?
|
| Hepatitis, Animal | 1 | 2018 | 19 | 0.160 |
Why?
|
| Ascorbic Acid | 1 | 2022 | 658 | 0.160 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2020 | 360 | 0.160 |
Why?
|
| Freeze Drying | 1 | 2018 | 97 | 0.150 |
Why?
|
| Choline | 1 | 2020 | 522 | 0.150 |
Why?
|
| Powders | 1 | 2018 | 79 | 0.150 |
Why?
|
| Glycine | 1 | 2022 | 672 | 0.150 |
Why?
|
| Serine | 1 | 2022 | 831 | 0.150 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2018 | 1810 | 0.150 |
Why?
|
| Cross-Over Studies | 3 | 2020 | 2107 | 0.150 |
Why?
|
| Connecticut | 1 | 2018 | 366 | 0.150 |
Why?
|
| Dietary Supplements | 3 | 2020 | 3445 | 0.150 |
Why?
|
| Inflammation | 3 | 2023 | 10873 | 0.140 |
Why?
|
| Epididymis | 1 | 2019 | 227 | 0.140 |
Why?
|
| Double-Blind Method | 3 | 2021 | 12466 | 0.140 |
Why?
|
| Receptors, LDL | 1 | 2020 | 493 | 0.140 |
Why?
|
| Enzymes | 1 | 2018 | 254 | 0.140 |
Why?
|
| Aged | 10 | 2024 | 171502 | 0.140 |
Why?
|
| Nutrition Policy | 1 | 2020 | 467 | 0.130 |
Why?
|
| Panniculitis | 1 | 2016 | 45 | 0.130 |
Why?
|
| Prospective Studies | 5 | 2023 | 54924 | 0.130 |
Why?
|
| Absorptiometry, Photon | 1 | 2022 | 1758 | 0.130 |
Why?
|
| Female | 15 | 2024 | 397187 | 0.120 |
Why?
|
| Mice, Knockout | 2 | 2022 | 14488 | 0.120 |
Why?
|
| Aged, 80 and over | 5 | 2024 | 59626 | 0.120 |
Why?
|
| Animals | 8 | 2022 | 169285 | 0.120 |
Why?
|
| Liver | 2 | 2022 | 7578 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 3 | 2022 | 22380 | 0.110 |
Why?
|
| Feces | 1 | 2020 | 1511 | 0.110 |
Why?
|
| Feasibility Studies | 2 | 2021 | 5315 | 0.100 |
Why?
|
| Energy Intake | 1 | 2020 | 2146 | 0.100 |
Why?
|
| Biological Transport | 1 | 2017 | 2085 | 0.100 |
Why?
|
| Longitudinal Studies | 3 | 2023 | 14783 | 0.090 |
Why?
|
| Linear Models | 1 | 2021 | 5884 | 0.090 |
Why?
|
| Blood Pressure | 3 | 2022 | 8543 | 0.090 |
Why?
|
| Humans | 16 | 2024 | 768171 | 0.090 |
Why?
|
| Cholesterol, LDL | 1 | 2020 | 2403 | 0.090 |
Why?
|
| Bacteria | 1 | 2022 | 2216 | 0.090 |
Why?
|
| Pilot Projects | 2 | 2021 | 8741 | 0.090 |
Why?
|
| Triglycerides | 1 | 2018 | 2464 | 0.090 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 26379 | 0.090 |
Why?
|
| Models, Animal | 1 | 2017 | 2122 | 0.090 |
Why?
|
| Guideline Adherence | 1 | 2020 | 2235 | 0.090 |
Why?
|
| C-Reactive Protein | 1 | 2022 | 3858 | 0.080 |
Why?
|
| Inflammation Mediators | 1 | 2018 | 1892 | 0.080 |
Why?
|
| Odds Ratio | 1 | 2022 | 9669 | 0.080 |
Why?
|
| Mice | 3 | 2022 | 82049 | 0.080 |
Why?
|
| Middle Aged | 7 | 2022 | 223487 | 0.080 |
Why?
|
| Insulin Resistance | 2 | 2020 | 3986 | 0.070 |
Why?
|
| Body Weight | 1 | 2018 | 4627 | 0.070 |
Why?
|
| Sex Factors | 1 | 2021 | 10632 | 0.070 |
Why?
|
| Logistic Models | 1 | 2022 | 13290 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 10763 | 0.070 |
Why?
|
| Follow-Up Studies | 2 | 2023 | 39354 | 0.060 |
Why?
|
| Anthocyanins | 1 | 2023 | 80 | 0.050 |
Why?
|
| Apoptosis | 1 | 2017 | 9527 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 11930 | 0.040 |
Why?
|
| Food Analysis | 1 | 2020 | 103 | 0.040 |
Why?
|
| Adult | 5 | 2022 | 223646 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 20762 | 0.040 |
Why?
|
| Risk Factors | 2 | 2023 | 74944 | 0.040 |
Why?
|
| Time Factors | 1 | 2018 | 40220 | 0.030 |
Why?
|
| Mice, Obese | 1 | 2016 | 418 | 0.030 |
Why?
|
| Apolipoproteins | 1 | 2017 | 328 | 0.030 |
Why?
|
| Nutrition Surveys | 1 | 2020 | 1738 | 0.030 |
Why?
|
| Antihypertensive Agents | 1 | 2022 | 2029 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2018 | 65379 | 0.020 |
Why?
|
| Weight Loss | 1 | 2022 | 2721 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2016 | 1904 | 0.020 |
Why?
|
| Weight Gain | 1 | 2016 | 2359 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2016 | 6431 | 0.010 |
Why?
|
| Young Adult | 2 | 2020 | 60066 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2016 | 4978 | 0.010 |
Why?
|
| Adolescent | 2 | 2020 | 89169 | 0.010 |
Why?
|
Concepts
(119)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(13)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_